MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy

American Journal of Pathology

Volumn 180, Issue 6, 2012, Pages 2548-2560

  Xu, Zhenhua ^a   Gong, Junsong ^a   Maiti, Debasish ^a   Vong, Linh ^b   Wu, Lijuan ^a   Schwarz, John J ^b   Duh, Elia J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2C; OXYGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RETINA BARRIER; CELL DEATH; CELL STRESS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; RETINOPATHY; VASCULARIZATION;

ANIMALS; APOPTOSIS; BLOOD-RETINAL BARRIER; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFANT, NEWBORN; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOGENIC REGULATORY FACTORS; OXIDATIVE STRESS; OXYGEN; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; RNA, SMALL INTERFERING;

EID: 84861635499     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.02.021     Document Type: Article

References (57)

1. M.E. Hartnett The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model Doc Ophthalmol 120 2010 25 39
2. P. Sapieha, J.S. Joyal, J.C. Rivera, E. Kermorvant-Duchemin, F. Sennlaub, P. Hardy, P. Lachapelle, S. Chemtob Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life J Clin Invest 120 2010 3022 3032
3. L.E. Smith Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture Invest Ophthalmol Vis Sci 49 2008 5177 5182
4. A. Madan, J.S. Penn Animal models of oxygen-induced retinopathy Front Biosci 8 2003 d1030 d1043
5. L.E. Smith, E. Wesolowski, A. McLellan, S.K. Kostyk, R. D'Amato, R. Sullivan, P.A. D'Amore Oxygen-induced retinopathy in the mouse Invest Ophthalmol Vis Sci 35 1994 101 111
6. A. Stahl, K.M. Connor, P. Sapieha, J. Chen, R.J. Dennison, N.M. Krah, M.R. Seaward, K.L. Willett, C.M. Aderman, K.I. Guerin, J. Hua, C. Lofqvist, A. Hellstrom, L.E. Smith The mouse retina as an angiogenesis model Invest Ophthalmol Vis Sci 51 2010 2813 2826
7. E. Kermorvant-Duchemin, P. Sapieha, M. Sirinyan, M. Beauchamp, D. Checchin, P. Hardy, F. Sennlaub, P. Lachapelle, S. Chemtob Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy Doc Ophthalmol 120 2009 51 60
8. W. Bi, C.J. Drake, J.J. Schwarz The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF Dev Biol 211 1999 255 267
9. Q. Lin, J. Lu, H. Yanagisawa, R. Webb, G.E. Lyons, J.A. Richardson, E.N. Olson Requirement of the MADS-box transcription factor MEF2C for vascular development Development 125 1998 4565 4574
10. Q. Lin, J. Schwarz, C. Bucana, E.N. Olson Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C Science 276 1997 1404 1407
11. P. Shore, A.D. Sharrocks The MADS-box family of transcription factors Eur J Biochem 229 1995 1 13
12. E.N. Olson, M. Perry, R.A. Schulz Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors Dev Biol 172 1995 2 14
13. M.J. Potthoff, E.N. Olson MEF2: a central regulator of diverse developmental programs Development 134 2007 4131 4140
14. B.M. Hosking, S.C. Wang, S.L. Chen, S. Penning, P. Koopman, G.E. Muscat SOX18 directly interacts with MEF2C in endothelial cells Biochem Biophys Res Commun 287 2001 493 500
15. D. Maiti, Z. Xu, E.J. Duh Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells Invest Ophthalmol Vis Sci 49 2008 3640 3648
16. P.A. Koni, S.K. Joshi, U.A. Temann, D. Olson, L. Burkly, R.A. Flavell Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow J Exp Med 193 2001 741 754
17. L.H. Vong, M.J. Ragusa, J.J. Schwarz Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses Genesis 43 2005 43 48
18. L. Vong, W. Bi, K.E. O'Connor-Halligan, C. Li, P. Cserjesi, J.J. Schwarz MEF2C is required for the normal allocation of cells between the ventricular and sinoatrial precursors of the primary heart field Dev Dyn 235 2006 1809 1821
19. P. Soriano Generalized lacZ expression with the ROSA26 Cre reporter strain Nat Genet 21 1999 70 71
20. K.M. Connor, N.M. Krah, R.J. Dennison, C.M. Aderman, J. Chen, K.I. Guerin, P. Sapieha, A. Stahl, K.L. Willett, L.E. Smith Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis Nat Protoc 4 2009 1565 1573
21. U. Ozerdem, K.A. Grako, K. Dahlin-Huppe, E. Monosov, W.B. Stallcup NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis Dev Dyn 222 2001 218 227
22. N.L. Derevjanik, S.A. Vinores, W.H. Xiao, K. Mori, T. Turon, T. Hudish, S. Dong, P.A. Campochiaro Quantitative assessment of the integrity of the blood-retinal barrier in mice Invest Ophthalmol Vis Sci 43 2002 2462 2467
23. H. Huang, S. Van de Veire, M. Dalal, R. Parlier, R.D. Semba, P. Carmeliet, S.A. Vinores Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration Invest Ophthalmol Vis Sci 52 2011 7565 7573
24. E. Im, A. Venkatakrishnan, A. Kazlauskas Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells Mol Biol Cell 16 2005 3488 3500
25. E. Im, A. Kazlauskas Regulating angiogenesis at the level of PtdIns-4,5-P2 EMBO J 25 2006 2075 2082
26. E. Im, R. Motiejunaite, J. Aranda, E.Y. Park, L. Federico, T.I. Kim, T. Clair, M.L. Stracke, S. Smyth, A. Kazlauskas Phospholipase Cγ activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression Mol Cell Biol 30 2010 2401 2410
27. D. Watanabe, H. Takagi, K. Suzuma, I. Suzuma, H. Oh, H. Ohashi, S. Kemmochi, A. Uemura, T. Ojima, E. Suganami, N. Miyamoto, Y. Sato, Y. Honda Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization Am J Pathol 164 2004 1827 1835
28. Z. Xu, D. Maiti, W. Kisiel, E.J. Duh Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells Arterioscler Thromb Vasc Biol 26 2006 2819 2825
29. J. Xu, N.L. Gong, I. Bodi, B.J. Aronow, P.H. Backx, J.D. Molkentin Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice J Biol Chem 281 2006 9152 9162
30. D. Khiem, J.G. Cyster, J.J. Schwarz, B.L. Black A p38 MAPK-MEF2C pathway regulates B-cell proliferation Proc Natl Acad Sci U S A 105 2008 17067 17072
31. H. Li, J.C. Radford, M.J. Ragusa, K.L. Shea, S.R. McKercher, J.D. Zaremba, W. Soussou, Z. Nie, Y.J. Kang, N. Nakanishi, S. Okamoto, A.J. Roberts, J.J. Schwarz, S.A. Lipton Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo Proc Natl Acad Sci U S A 105 2008 9397 9402
32. M.P. Verzi, P. Agarwal, C. Brown, D.J. McCulley, J.J. Schwarz, B.L. Black The transcription factor MEF2C is required for craniofacial development Dev Cell 12 2007 645 652
33. P.R. Wilker, M. Kohyama, M.M. Sandau, J.C. Albring, O. Nakagawa, J.J. Schwarz, K.M. Murphy Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation Nat Immunol 9 2008 603 612
34. S. Claxton, V. Kostourou, S. Jadeja, P. Chambon, K. Hodivala-Dilke, M. Fruttiger Efficient, inducible Cre-recombinase activation in vascular endothelium Genesis 46 2008 74 80
35. K.M. Connor, J.P. SanGiovanni, C. Lofqvist, C.M. Aderman, J. Chen, A. Higuchi, S. Hong, E.A. Pravda, S. Majchrzak, D. Carper, A. Hellstrom, J.X. Kang, E.Y. Chew, N. Salem Jr, C.N. Serhan, L.E. Smith Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis Nat Med 13 2007 868 873
36. J.S. Joyal, N. Sitaras, F. Binet, J.C. Rivera, A. Stahl, K. Zaniolo, Z. Shao, A. Polosa, T. Zhu, D. Hamel, M. Djavari, D. Kunik, J.C. Honore, E. Picard, A. Zabeida, D.R. Varma, G. Hickson, J. Mancini, M. Klagsbrun, S. Costantino, C. Beausejour, P. Lachapelle, L.E. Smith, S. Chemtob, P. Sapieha Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A Blood 117 2011 6024 6035
37. C. Lange, C. Ehlken, A. Stahl, G. Martin, L. Hansen, H.T. Agostini Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model Graefes Arch Clin Exp Ophthalmol 247 2009 1205 1211
38. T. Alon, I. Hemo, A. Itin, J. Pe'er, J. Stone, E. Keshet Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat Med 1 1995 1024 1028
39. P. Escher, D.F. Schorderet, S. Cottet Altered expression of the transcription factor Mef2c during retinal degeneration in Rpe65-/- mice Invest Ophthalmol Vis Sci 52 2011 5933 5940
40. J.L. Kielczewski, P. Hu, L.C. Shaw, S. Li Calzi, R.N. Mames, T.A. Gardiner, E. McFarland, T. Chan-Ling, M.B. Grant Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury Am J Pathol 178 2011 1517 1528
41. J. Dulak, A. Loboda, A. Jozkowicz Effect of heme oxygenase-1 on vascular function and disease Curr Opin Lipidol 19 2008 505 512
42. J. Dulak, J. Deshane, A. Jozkowicz, A. Agarwal Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis Circulation 117 2008 231 241
43. A. Yachie, Y. Niida, T. Wada, N. Igarashi, H. Kaneda, T. Toma, K. Ohta, Y. Kasahara, S. Koizumi Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency J Clin Invest 103 1999 129 135
44. R. Constien, A. Forde, B. Liliensiek, H.J. Grone, P. Nawroth, G. Hammerling, B. Arnold Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line Genesis 30 2001 36 44
45. J.L. Kielczewski, Y.P. Jarajapu, E.L. McFarland, J. Cai, A. Afzal, S. Li Calzi, K.H. Chang, T. Lydic, L.C. Shaw, J. Busik, J. Hughes, A.J. Cardounel, K. Wilson, T.J. Lyons, M.E. Boulton, R.N. Mames, T. Chan-Ling, M.B. Grant Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation Circ Res 105 2009 897 905
46. C. Lofqvist, J. Chen, K.M. Connor, A.C. Smith, C.M. Aderman, N. Liu, J.E. Pintar, T. Ludwig, A. Hellstrom, L.E. Smith IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth Proc Natl Acad Sci U S A 104 2007 10589 10594
47. J. Chen, K.M. Connor, C.M. Aderman, L.E. Smith Erythropoietin deficiency decreases vascular stability in mice J Clin Invest 118 2008 526 533
48. A. Ohlmann, R. Seitz, B. Braunger, D. Seitz, M.R. Bosl, E.R. Tamm Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice J Neurosci 30 2010 183 193
49. S. Wang, Z. Wu, C.M. Sorenson, J. Lawler, N. Sheibani Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration Dev Dyn 228 2003 630 642
50. T.A. Gardiner, D.S. Gibson, T.E. de Gooyer, V.F. de la Cruz, D.M. McDonald, A.W. Stitt Inhibition of tumor necrosis factor-α improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy Am J Pathol 166 2005 637 644
51. Y. Saito, P. Geisen, A. Uppal, M.E. Hartnett Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity Mol Vis 13 2007 840 853
52. Y. Saito, A. Uppal, G. Byfield, S. Budd, M.E. Hartnett Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model Invest Ophthalmol Vis Sci 49 2008 1591 1598
53. M. Al-Shabrawey, M. Bartoli, A.B. El-Remessy, D.H. Platt, S. Matragoon, M.A. Behzadian, R.W. Caldwell, R.B. Caldwell Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy Am J Pathol 167 2005 599 607
54. M.H. Beauchamp, F. Sennlaub, G. Speranza, F. Gobeil Jr, D. Checchin, E. Kermorvant-Duchemin, D. Abran, P. Hardy, P. Lachapelle, D.R. Varma, S. Chemtob Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy Free Radic Biol Med 37 2004 1885 1894
55. S.E. Brooks, X. Gu, S. Samuel, D.M. Marcus, M. Bartoli, P.L. Huang, R.B. Caldwell Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice Invest Ophthalmol Vis Sci 42 2001 222 228
56. E. Kermorvant-Duchemin, F. Sennlaub, M. Sirinyan, S. Brault, G. Andelfinger, A. Kooli, S. Germain, H. Ong, P. d'Orleans-Juste, F. Gobeil Jr, T. Zhu, C. Boisvert, P. Hardy, K. Jain, J.R. Falck, M. Balazy, S. Chemtob Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration Nat Med 11 2005 1339 1345
57. E.J. Duh Sema 3A resists retinal revascularization Blood 117 2011 5785 5786